Carrie Sougnez

Biochemistry, Genetics and Molecular Biology · Life Sciences

76h-index129.3kcitations173works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(52), Chronic Lymphocytic Leukemia Research(26), Brain Metastases and Treatment(18), Lung Cancer Treatments and Mutations(15), RNA modifications and cancer(14)

Publications152 total

Supplementary File 1 from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
2023Open Access
Supplementary Table S1 from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
2023Open Access
Supplementary File Legends from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
2023Open Access
Supplementary Table S3 from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
2023Open Access
Supplementary File 2 from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
2023Open Access
Supplementary File 1 from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
2023Open Access
Supplementary File 3 from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
2023Open Access
Supplementary Table S2 from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
2023Open Access
Supplementary Table S2 from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
2023Open Access
Supplementary File 3 from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
2023Open Access
Supplementary Methods, Figures S1 - S20 from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
2023Open Access
Supplementary Methods, Figures S1 - S20 from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
2023Open Access
Supplementary Table S3 from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
2023Open Access
Supplementary File Legends from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
2023Open Access
Supplementary File 2 from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
2023Open Access
Data from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
2023Open Access
Supplementary Table S1 from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
2023Open Access
Data from Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
2023Open Access
CD38 in Advanced Prostate Cancers
European Urology·2021· 38 citedOpen Access
Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network
UNC Libraries·2020· 31 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Gad Getz(36), Kristian Cibulskis(36), Stacey Gabriel(35), Matthew Meyerson(25), Michael S. Lawrence(25), Eric S. Lander(24), Scott L. Carter(23), Andrey Sivachenko(18), Levi A. Garraway(16), Todd R. Golub(14), Robert C. Onofrio(13), Daniel Auclair(13), Gordon Saksena(13), Wendy Winckler(12), Aaron McKenna(11), Kristin Ardlie(10), Alex H. Ramos(10), Eric S. Lander(9), Rameen Beroukhim(9), Petar Stojanov(9)